BioArctic extends the research collaboration with Uppsala University regarding new antibody technology

Stockholm, Sweden, May 14, 2018 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that the company has signed an extended research collaboration agreement with Uppsala University, Department of Pharmaceutical Biosciences. The extended research collaboration concerns technologies for increased passage across the blood-brain barrier and BioArctic will contribute financial support for a three year post-doc research position. The blood-brain barrier is a membrane that controls the exchange of substances between the blood and the brain. The barrier protects the brain from